- Investing Ideas
- Chinese Pharmaceuticals & Biotech Spotless Management
Chinese Pharmaceuticals & Biotech Spotless Management
Results
3
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
3 companies
WuXi AppTec
Market Cap: CN¥424.8b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥142.70
7D
13.7%
1Y
56.5%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥49.8b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥110.72
7D
-4.2%
1Y
16.3%
Xiamen Amoytop Biotech
Market Cap: CN¥22.3b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥54.58
7D
-5.7%
1Y
-36.2%